~5 spots leftby Dec 2027

Water Ingestion for Heart Transplant Patients

Recruiting in Palo Alto (17 mi)
+1 other location
Overseen bySatish R Raj, MD, MSCI
Age: 18+
Sex: Any
Travel: May Be Covered
Time Reimbursement: Varies
Trial Phase: Academic
Waitlist Available
Sponsor: Satish R. Raj
No Placebo Group

Trial Summary

What is the purpose of this trial?In this study the investigators propose to assess the hemodynamic response to the ingestion of 16 fl oz of water. The investigators will test the hypothesis that water ingestion will increase the systemic vascular resistance.

Eligibility Criteria

This trial is for heart transplant patients over 18 years old who are scheduled for a clinical right heart catheterization. It's not suitable for those with significant tricuspid regurgitation, difficulty swallowing large amounts of water, or severe kidney disease where drinking water could be harmful.

Inclusion Criteria

I have had a heart transplant and am scheduled for a heart catheterization.
I am over 18 years old.

Exclusion Criteria

I have severe leakage in my heart's tricuspid valve.
I have a serious health condition like advanced kidney disease.
I cannot safely drink 500 ml of water.

Participant Groups

The study is examining the effects of drinking 16 fl oz of water on blood vessel resistance in heart transplant recipients. The goal is to see if consuming this amount of water will increase the resistance in systemic blood vessels.
1Treatment groups
Experimental Treatment
Group I: 1Experimental Treatment1 Intervention
water ingestion

Find a Clinic Near You

Research Locations NearbySelect from list below to view details:
Vanderbilt UniversityNashville, TN
Tennessee Valley Health Systems (Nashville VA)Nashville, TN
Loading ...

Who Is Running the Clinical Trial?

Satish R. RajLead Sponsor
National Center for Research Resources (NCRR)Collaborator

References